CHMP recommends Yuvanci (macitentan + tadalafil) to treat pulmonary arterial hypertension – Johnson & Johnson
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Yuvanci, intended for the… read more.